JAG
Journey Advisory Group’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $993K | Sell |
40,965
-1,434
| -3% | -$34.8K | 0.08% | 162 |
|
|
2025
Q1 | $1.07M | Sell |
42,399
-13,636
| -24% | -$346K | 0.09% | 147 |
|
|
2024
Q4 | $1.57M | Hold |
56,035
| – | – | 0.19% | 87 |
|
|
2024
Q3 | $1.57M | Hold |
56,035
| – | – | 0.19% | 87 |
|
|
2024
Q2 | $1.57M | Sell |
56,035
-3,164
| -5% | -$88.5K | 0.19% | 86 |
|
|
2024
Q1 | $1.64M | Sell |
59,199
-14,626
| -20% | -$406K | 0.2% | 94 |
|
|
2023
Q4 | $2.13M | Sell |
73,825
-27,618
| -27% | -$795K | 0.29% | 82 |
|
|
2023
Q3 | $3.36M | Sell |
101,443
-6,761
| -6% | -$224K | 0.5% | 61 |
|
|
2023
Q2 | $3.97M | Sell |
108,204
-10,136
| -9% | -$372K | 0.59% | 53 |
|
|
2023
Q1 | $4.83M | Sell |
118,340
-11,657
| -9% | -$476K | 0.76% | 37 |
|
|
2022
Q4 | $6.66M | Buy |
129,997
+31,339
| +32% | +$1.61M | 1.66% | 10 |
|
|
2022
Q3 | $4.32M | Buy |
98,658
+6,956
| +8% | +$304K | 1.1% | 19 |
|
|
2022
Q2 | $4.64M | Buy |
91,702
+22,011
| +32% | +$1.11M | 1.07% | 20 |
|
|
2022
Q1 | $3.61M | Buy |
69,691
+5,397
| +8% | +$279K | 0.91% | 26 |
|
|
2021
Q4 | $3.8M | Buy |
64,294
+7,282
| +13% | +$430K | 1.05% | 24 |
|
|
2021
Q3 | $2.45M | Buy |
57,012
+1,570
| +3% | +$67.5K | 0.79% | 29 |
|
|
2021
Q2 | $2.17M | Buy |
55,442
+771
| +1% | +$30.2K | 0.69% | 39 |
|
|
2021
Q1 | $1.98M | Buy |
54,671
+3
| +0% | +$109 | 0.69% | 39 |
|
|
2020
Q4 | $2.01M | Buy |
+54,668
| New | +$2.01M | 0.75% | 38 |
|